Kontrol will be very successful with Biocloud..I have spoken with Paul few times in the past. He is well focused in taking this company to a greater level. This is a new product and the market needs to understand the benefits to out weight the cost of the product.. give some time.. Bicloud is not competing with the vaccine,,